Listar Bordeaux Population Health Research Center (BPH) - UMR 1219 por autor "RASCHI, E."
Mostrando ítems 1-7 de 7
-
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis
MOUCHET, Julie; SALVO, Francesco; RASCHI, E. ...
(Vaccine. vol. 36, n° 12, pp. 1548-1555, 2018-03-14)Article de revue -
Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction
RASCHI, E.; SALVO, Francesco; LA PLACA, M. ...
(Journal of the European Academy of Dermatology and Venereology. vol. 34, n° 8, pp. e430-e431, 2020)Article de revue -
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database
GOUVERNEUR, Amandine; LAIR, Athenais; ARNAUD, Mickael ...
(Lancet Diabetes and Endocrinology. vol. 8, n° 5, pp. 365-367, 2020)Article de revue -
DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus
PARIENTE, Antoine; LABAT, Vanessa; MANSIAUX, Yohann ...
(Drug Safety. vol. 43, n° 8, pp. 767-774, 2020)Article de revue -
Risk of bradyarrhythmia related to ticagrelor: a systematic review and meta-analysis
PUJADE, Iris; PERINO, Justine; MATHIEU, Clement
...
(Pharmacological Research. pp. 105089, 2020)Article de revue -
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis
MOUCHET, Julie; SALVO, Francesco; RASCHI, E. ...
(Pharmacological Research. vol. 132, pp. 108-118, 2018-06)Article de revue -
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
RASCHI, E.; POLUZZI, E.; SALVO, Francesco...
(Nutrition, metabolism, and cardiovascular diseases. vol. 28, n° 6, pp. 533-542, 2018-06)Article de revue